pac.dog pac.dog /orgs

MMV MEDICINES FOR MALARIA VENTURE

Sign in to add to a watchlist →

lobbying_client · US · canonical: mmv medicines malaria venture · 1 alias · 0 outbound · 7 inbound

Activity

Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.

  1. 2026-05-18 · lobbied by Susan Sweat · lda_lobbyist_client
  2. 2026-05-18 · lobbied by Erik Fatemi · lda_lobbyist_client
  3. 2026-05-18 · lobbied by Wendy Sammons-Jackson · lda_lobbyist_client
  4. 2026-05-18 · lobbied by Steve Marchese · lda_lobbyist_client
  5. 2026-05-18 · lobbied by Jonathan Miller · lda_lobbyist_client
  6. 2026-05-18 · lobbied by Adam Yezerski · lda_lobbyist_client
  7. 2026-01-01 · lobbied for by CORNERSTONE GOVERNMENT AFFAIRS, INC. $50,000 · lda_filing

Lobbying disclosures — as CLIENT (2)

Filings where this org hired a lobbying firm. Income + expenses come from the LDA disclosure.

PostedFilingYearPeriodRegistrant (lobbying firm)IncomeExpenses
2026-04-081st Quarter - Report2026first_quarter75557$50,000
2025-04-041st Quarter - Report2025first_quarter75557$50,000

Aliases (1)

sourceidname at sourcejurisdictionconfidencelinked bylinked at
lda_client57713MMV MEDICINES FOR MALARIA VENTUREUSgoldbackfill_0029

Outbound edges (0)

None recorded.

Inbound edges (7)

datefromtypeamountsource
Adam Yezerskilobbied_forlda_lobbyist_client
Jonathan Millerlobbied_forlda_lobbyist_client
Steve Marcheselobbied_forlda_lobbyist_client
Wendy Sammons-Jacksonlobbied_forlda_lobbyist_client
Erik Fatemilobbied_forlda_lobbyist_client
Susan Sweatlobbied_forlda_lobbyist_client
2026-01-01CORNERSTONE GOVERNMENT AFFAIRS, INC.lobbies_for$50,000lda_filing

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.

Estimated value: $180/mo per user — but we made it free.